Carvedilol 12.5mg tablets

מדינה: הממלכה המאוחדת

שפה: אנגלית

מקור: MHRA (Medicines & Healthcare Products Regulatory Agency)

מרכיב פעיל:

Carvedilol

זמין מ:

DE Pharmaceuticals

קוד ATC:

C07AG02

INN (שם בינלאומי):

Carvedilol

כמות:

12.5mg

טופס פרצבטיות:

Oral tablet

מסלול נתינה (של תרופות):

Oral

סיווג:

No Controlled Drug Status

סוג מרשם:

Valid as a prescribable product

leaflet_short:

BNF: 02040000

עלון מידע

A
NN
EXU
RE-
1
(Ref.
SOP.
No.:
DFD080)
ART
WORK
APPR
OVAL
FORM
_R_
_elon_
_@hem _
PATIENT
INFORMATION
LEAFLET:
lnfonnatfon
for
the
user
CARVEDI
LOL
3.125
mg,
6.25
mg,
12.5
mg
&
25
mg
TABL
ETS
Read
111
of
this feaRet carefully before you atart taking this medicine
btcause
h
contains
Important I
nformation
f
or
yo
u.
Keep
thi
s
leal1el.
You
may need to
read
It
again.
If
you
have further questions. please ask
)'OUr
dod.ororyour
pharmaci
st
This medicine
has
been presttibed for
you
only.
Do
nol
pas.sit
on to
olhers;
it
may
harm
them,
eve
n
if
their symptoms are the same
as
you
which
Is
being
tr
ei
Hed
by
medicines glven
In
to
your
11
etns (lntrav

מאפייני מוצר

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Carvedilol 12.5 mg Tablets
SUMMARY OF PRODUCT CHARACTERISTICS
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 12.5 mg of Carvedilol
Excipient(s) with known effect: Each tablet contains 62.94 mg of
lactose
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet
Carvedilol Tablets are cream coloured, circular, biconvex tablets,
8.30 mm-8.70 mm
in diameter, marked ‘C12’ on one face and plain on the reverse
face.
SUMMARY OF PRODUCT CHARACTERISTICS
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Essential hypertension
Chronic stable angina pectoris
Adjunctive treatment of moderate to severe stable chronic heart
failure.
SUMMARY OF PRODUCT CHARACTERISTICS
4
CLINICAL PARTICULARS
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
ESSENTIAL HYPERTENSION
Carvedilol
may
be
used
for
the
treatment
of
hypertension
alone
or
in
combination with other antihypertensives, especially thiazide
diuretics. Once
daily dosing is recommended, however the recommended maximum single
dose is 25 mg and the recommended maximum daily dose is 50 mg.
_ _
_Adults:_
The recommended initial dose is 12.5 mg once a day for the first two
days.
Thereafter the treatment is continued at the dose 25 mg/day. If
necessary, the
dose may be further increased gradually at intervals of two weeks or
more
rarely.
_Elderly:_
The recommended initial dose in hypertension is 12.5 mg once a day
which
may also be sufficient for continued treatment.
However, if the therapeutic response is inadequate at this dose, the
dose may
be further increased gradually at intervals of two weeks or more
rarely.
CHRONIC STABLE ANGINA PECTORIS:
A twice-daily regimen is recommended.
_Adults:_
The recommended initial dosage is 12.5 mg twice a day for the first
two days.
Thereafter, the treatment is continued at the dose 25 mg twice a day.
If
necessary, the dose may be further increased gradually at intervals of
two
weeks or more rarely to the recommended maximum dose of 100 mg